nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP1A2—Carmustine—lymphatic system cancer	0.177	0.34	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.144	0.277	CbGbCtD
Mexiletine—CYP3A4—Cytarabine—lymphatic system cancer	0.0634	0.122	CbGbCtD
Mexiletine—CYP3A4—Teniposide—lymphatic system cancer	0.0624	0.12	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0437	0.0838	CbGbCtD
Mexiletine—CYP3A4—Vincristine—lymphatic system cancer	0.0301	0.0577	CbGbCtD
Mexiletine—Visual impairment—Fludarabine—lymphatic system cancer	0.00222	0.00462	CcSEcCtD
Mexiletine—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00218	0.00455	CcSEcCtD
Mexiletine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00217	0.00454	CcSEcCtD
Mexiletine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00205	0.00429	CcSEcCtD
Mexiletine—Leukopenia—Teniposide—lymphatic system cancer	0.00204	0.00425	CcSEcCtD
Mexiletine—Alopecia—Fludarabine—lymphatic system cancer	0.00203	0.00424	CcSEcCtD
Mexiletine—Ataxia—Carmustine—lymphatic system cancer	0.002	0.00417	CcSEcCtD
Mexiletine—Hypertension—Teniposide—lymphatic system cancer	0.00197	0.0041	CcSEcCtD
Mexiletine—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00196	0.0041	CcSEcCtD
Mexiletine—Chest pain—Teniposide—lymphatic system cancer	0.00194	0.00405	CcSEcCtD
Mexiletine—Ataxia—Vincristine—lymphatic system cancer	0.00191	0.00398	CcSEcCtD
Mexiletine—Confusional state—Teniposide—lymphatic system cancer	0.00187	0.00391	CcSEcCtD
Mexiletine—Oedema—Teniposide—lymphatic system cancer	0.00186	0.00388	CcSEcCtD
Mexiletine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00186	0.00388	CcSEcCtD
Mexiletine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00186	0.00388	CcSEcCtD
Mexiletine—Dysphagia—Carmustine—lymphatic system cancer	0.00184	0.00384	CcSEcCtD
Mexiletine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00182	0.0038	CcSEcCtD
Mexiletine—Malaise—Fludarabine—lymphatic system cancer	0.0018	0.00377	CcSEcCtD
Mexiletine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0018	0.00375	CcSEcCtD
Mexiletine—Leukopenia—Fludarabine—lymphatic system cancer	0.00179	0.00374	CcSEcCtD
Mexiletine—Hypotension—Teniposide—lymphatic system cancer	0.00174	0.00362	CcSEcCtD
Mexiletine—Convulsion—Fludarabine—lymphatic system cancer	0.00173	0.00362	CcSEcCtD
Mexiletine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00172	0.0036	CcSEcCtD
Mexiletine—Neutropenia—Carmustine—lymphatic system cancer	0.00172	0.00359	CcSEcCtD
Mexiletine—Arthralgia—Fludarabine—lymphatic system cancer	0.0017	0.00356	CcSEcCtD
Mexiletine—Discomfort—Fludarabine—lymphatic system cancer	0.00168	0.00351	CcSEcCtD
Mexiletine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00168	0.0035	CcSEcCtD
Mexiletine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00166	0.00347	CcSEcCtD
Mexiletine—Dyspnoea—Teniposide—lymphatic system cancer	0.00166	0.00346	CcSEcCtD
Mexiletine—Confusional state—Fludarabine—lymphatic system cancer	0.00165	0.00344	CcSEcCtD
Mexiletine—Neutropenia—Vincristine—lymphatic system cancer	0.00164	0.00343	CcSEcCtD
Mexiletine—Depression—Carmustine—lymphatic system cancer	0.00163	0.00341	CcSEcCtD
Mexiletine—Oedema—Fludarabine—lymphatic system cancer	0.00163	0.00341	CcSEcCtD
Mexiletine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00162	0.00337	CcSEcCtD
Mexiletine—Vomiting—Mechlorethamine—lymphatic system cancer	0.0016	0.00335	CcSEcCtD
Mexiletine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0016	0.00334	CcSEcCtD
Mexiletine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.0016	0.00334	CcSEcCtD
Mexiletine—Rash—Mechlorethamine—lymphatic system cancer	0.00159	0.00332	CcSEcCtD
Mexiletine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00159	0.00331	CcSEcCtD
Mexiletine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00158	0.0033	CcSEcCtD
Mexiletine—Speech disorder—Methotrexate—lymphatic system cancer	0.00158	0.00329	CcSEcCtD
Mexiletine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00157	0.00329	CcSEcCtD
Mexiletine—Depression—Vincristine—lymphatic system cancer	0.00156	0.00326	CcSEcCtD
Mexiletine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00153	0.0032	CcSEcCtD
Mexiletine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00152	0.00318	CcSEcCtD
Mexiletine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00152	0.00317	CcSEcCtD
Mexiletine—Nausea—Mechlorethamine—lymphatic system cancer	0.0015	0.00313	CcSEcCtD
Mexiletine—Alopecia—Bleomycin—lymphatic system cancer	0.00149	0.00311	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00149	0.00311	CcSEcCtD
Mexiletine—Abdominal pain—Teniposide—lymphatic system cancer	0.00147	0.00307	CcSEcCtD
Mexiletine—Body temperature increased—Teniposide—lymphatic system cancer	0.00147	0.00307	CcSEcCtD
Mexiletine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00147	0.00306	CcSEcCtD
Mexiletine—Hallucination—Carmustine—lymphatic system cancer	0.00146	0.00306	CcSEcCtD
Mexiletine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00146	0.00306	CcSEcCtD
Mexiletine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00146	0.00304	CcSEcCtD
Mexiletine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00144	0.003	CcSEcCtD
Mexiletine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00142	0.00297	CcSEcCtD
Mexiletine—Visual impairment—Carmustine—lymphatic system cancer	0.00142	0.00296	CcSEcCtD
Mexiletine—Fatigue—Fludarabine—lymphatic system cancer	0.00141	0.00294	CcSEcCtD
Mexiletine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.0014	0.00292	CcSEcCtD
Mexiletine—Hallucination—Vincristine—lymphatic system cancer	0.0014	0.00292	CcSEcCtD
Mexiletine—Constipation—Fludarabine—lymphatic system cancer	0.0014	0.00292	CcSEcCtD
Mexiletine—Pain—Fludarabine—lymphatic system cancer	0.0014	0.00292	CcSEcCtD
Mexiletine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00139	0.00291	CcSEcCtD
Mexiletine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00137	0.00286	CcSEcCtD
Mexiletine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00137	0.00286	CcSEcCtD
Mexiletine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00136	0.00284	CcSEcCtD
Mexiletine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00136	0.00283	CcSEcCtD
Mexiletine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00135	0.00281	CcSEcCtD
Mexiletine—Asthenia—Teniposide—lymphatic system cancer	0.00133	0.00278	CcSEcCtD
Mexiletine—Malaise—Bleomycin—lymphatic system cancer	0.00132	0.00276	CcSEcCtD
Mexiletine—Arrhythmia—Carmustine—lymphatic system cancer	0.00131	0.00274	CcSEcCtD
Mexiletine—Leukopenia—Bleomycin—lymphatic system cancer	0.00131	0.00274	CcSEcCtD
Mexiletine—Alopecia—Carmustine—lymphatic system cancer	0.0013	0.00271	CcSEcCtD
Mexiletine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00129	0.0027	CcSEcCtD
Mexiletine—Diarrhoea—Teniposide—lymphatic system cancer	0.00127	0.00265	CcSEcCtD
Mexiletine—Chest pain—Bleomycin—lymphatic system cancer	0.00125	0.00261	CcSEcCtD
Mexiletine—Alopecia—Vincristine—lymphatic system cancer	0.00124	0.00259	CcSEcCtD
Mexiletine—Discomfort—Bleomycin—lymphatic system cancer	0.00123	0.00258	CcSEcCtD
Mexiletine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00122	0.00255	CcSEcCtD
Mexiletine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00121	0.00252	CcSEcCtD
Mexiletine—Confusional state—Bleomycin—lymphatic system cancer	0.00121	0.00252	CcSEcCtD
Mexiletine—Vision blurred—Carmustine—lymphatic system cancer	0.00121	0.00252	CcSEcCtD
Mexiletine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0012	0.00251	CcSEcCtD
Mexiletine—Tremor—Carmustine—lymphatic system cancer	0.0012	0.0025	CcSEcCtD
Mexiletine—Oedema—Bleomycin—lymphatic system cancer	0.0012	0.0025	CcSEcCtD
Mexiletine—Vomiting—Teniposide—lymphatic system cancer	0.00118	0.00247	CcSEcCtD
Mexiletine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00117	0.00245	CcSEcCtD
Mexiletine—Asthenia—Fludarabine—lymphatic system cancer	0.00117	0.00245	CcSEcCtD
Mexiletine—Rash—Teniposide—lymphatic system cancer	0.00117	0.00245	CcSEcCtD
Mexiletine—Dermatitis—Teniposide—lymphatic system cancer	0.00117	0.00244	CcSEcCtD
Mexiletine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00117	0.00243	CcSEcCtD
Mexiletine—Headache—Teniposide—lymphatic system cancer	0.00116	0.00243	CcSEcCtD
Mexiletine—Leukopenia—Carmustine—lymphatic system cancer	0.00115	0.00239	CcSEcCtD
Mexiletine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00112	0.00234	CcSEcCtD
Mexiletine—Hypotension—Bleomycin—lymphatic system cancer	0.00112	0.00234	CcSEcCtD
Mexiletine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00112	0.00233	CcSEcCtD
Mexiletine—Convulsion—Carmustine—lymphatic system cancer	0.00111	0.00232	CcSEcCtD
Mexiletine—Hypertension—Carmustine—lymphatic system cancer	0.00111	0.00231	CcSEcCtD
Mexiletine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0011	0.00231	CcSEcCtD
Mexiletine—Nausea—Teniposide—lymphatic system cancer	0.0011	0.0023	CcSEcCtD
Mexiletine—Leukopenia—Vincristine—lymphatic system cancer	0.00109	0.00228	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00109	0.00228	CcSEcCtD
Mexiletine—Chest pain—Carmustine—lymphatic system cancer	0.00109	0.00228	CcSEcCtD
Mexiletine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00108	0.00224	CcSEcCtD
Mexiletine—Malaise—Mitoxantrone—lymphatic system cancer	0.00107	0.00224	CcSEcCtD
Mexiletine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00107	0.00223	CcSEcCtD
Mexiletine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00107	0.00222	CcSEcCtD
Mexiletine—Convulsion—Vincristine—lymphatic system cancer	0.00106	0.00221	CcSEcCtD
Mexiletine—Hypertension—Vincristine—lymphatic system cancer	0.00106	0.0022	CcSEcCtD
Mexiletine—Confusional state—Carmustine—lymphatic system cancer	0.00105	0.0022	CcSEcCtD
Mexiletine—Oedema—Carmustine—lymphatic system cancer	0.00105	0.00218	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00104	0.00218	CcSEcCtD
Mexiletine—Visual disturbance—Methotrexate—lymphatic system cancer	0.00104	0.00217	CcSEcCtD
Mexiletine—Vomiting—Fludarabine—lymphatic system cancer	0.00104	0.00217	CcSEcCtD
Mexiletine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00103	0.00215	CcSEcCtD
Mexiletine—Rash—Fludarabine—lymphatic system cancer	0.00103	0.00215	CcSEcCtD
Mexiletine—Dermatitis—Fludarabine—lymphatic system cancer	0.00103	0.00215	CcSEcCtD
Mexiletine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00103	0.00215	CcSEcCtD
Mexiletine—Pain—Bleomycin—lymphatic system cancer	0.00102	0.00214	CcSEcCtD
Mexiletine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00102	0.00214	CcSEcCtD
Mexiletine—Headache—Fludarabine—lymphatic system cancer	0.00102	0.00214	CcSEcCtD
Mexiletine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00101	0.00212	CcSEcCtD
Mexiletine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00101	0.00212	CcSEcCtD
Mexiletine—Discomfort—Mitoxantrone—lymphatic system cancer	0.001	0.00209	CcSEcCtD
Mexiletine—Oedema—Vincristine—lymphatic system cancer	0.000998	0.00208	CcSEcCtD
Mexiletine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000987	0.00206	CcSEcCtD
Mexiletine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00098	0.00205	CcSEcCtD
Mexiletine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000977	0.00204	CcSEcCtD
Mexiletine—Hypotension—Carmustine—lymphatic system cancer	0.000977	0.00204	CcSEcCtD
Mexiletine—Oedema—Mitoxantrone—lymphatic system cancer	0.000972	0.00203	CcSEcCtD
Mexiletine—Nausea—Fludarabine—lymphatic system cancer	0.00097	0.00203	CcSEcCtD
Mexiletine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000965	0.00201	CcSEcCtD
Mexiletine—Shock—Mitoxantrone—lymphatic system cancer	0.000956	0.002	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000952	0.00199	CcSEcCtD
Mexiletine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000952	0.00199	CcSEcCtD
Mexiletine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000947	0.00198	CcSEcCtD
Mexiletine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00094	0.00196	CcSEcCtD
Mexiletine—Paraesthesia—Carmustine—lymphatic system cancer	0.000939	0.00196	CcSEcCtD
Mexiletine—Hypotension—Vincristine—lymphatic system cancer	0.000932	0.00195	CcSEcCtD
Mexiletine—Dyspnoea—Carmustine—lymphatic system cancer	0.000932	0.00195	CcSEcCtD
Mexiletine—Somnolence—Carmustine—lymphatic system cancer	0.000929	0.00194	CcSEcCtD
Mexiletine—Ataxia—Methotrexate—lymphatic system cancer	0.000926	0.00193	CcSEcCtD
Mexiletine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00091	0.0019	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000909	0.0019	CcSEcCtD
Mexiletine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000908	0.0019	CcSEcCtD
Mexiletine—Paraesthesia—Vincristine—lymphatic system cancer	0.000896	0.00187	CcSEcCtD
Mexiletine—Pain—Carmustine—lymphatic system cancer	0.000894	0.00187	CcSEcCtD
Mexiletine—Constipation—Carmustine—lymphatic system cancer	0.000894	0.00187	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000885	0.00185	CcSEcCtD
Mexiletine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000882	0.00184	CcSEcCtD
Mexiletine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000873	0.00182	CcSEcCtD
Mexiletine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000866	0.00181	CcSEcCtD
Mexiletine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000864	0.0018	CcSEcCtD
Mexiletine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000861	0.0018	CcSEcCtD
Mexiletine—Fatigue—Vincristine—lymphatic system cancer	0.00086	0.0018	CcSEcCtD
Mexiletine—Asthenia—Bleomycin—lymphatic system cancer	0.000859	0.00179	CcSEcCtD
Mexiletine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000855	0.00179	CcSEcCtD
Mexiletine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000855	0.00178	CcSEcCtD
Mexiletine—Constipation—Vincristine—lymphatic system cancer	0.000853	0.00178	CcSEcCtD
Mexiletine—Pain—Vincristine—lymphatic system cancer	0.000853	0.00178	CcSEcCtD
Mexiletine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000838	0.00175	CcSEcCtD
Mexiletine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000835	0.00174	CcSEcCtD
Mexiletine—Pain—Mitoxantrone—lymphatic system cancer	0.000831	0.00173	CcSEcCtD
Mexiletine—Constipation—Mitoxantrone—lymphatic system cancer	0.000831	0.00173	CcSEcCtD
Mexiletine—Body temperature increased—Carmustine—lymphatic system cancer	0.000826	0.00172	CcSEcCtD
Mexiletine—Abdominal pain—Carmustine—lymphatic system cancer	0.000826	0.00172	CcSEcCtD
Mexiletine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000816	0.0017	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000816	0.0017	CcSEcCtD
Mexiletine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000801	0.00167	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—lymphatic system cancer	0.000796	0.00166	CcSEcCtD
Mexiletine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000795	0.00166	CcSEcCtD
Mexiletine—Abdominal pain—Vincristine—lymphatic system cancer	0.000789	0.00165	CcSEcCtD
Mexiletine—Body temperature increased—Vincristine—lymphatic system cancer	0.000789	0.00165	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000784	0.00164	CcSEcCtD
Mexiletine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00077	0.00161	CcSEcCtD
Mexiletine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000768	0.0016	CcSEcCtD
Mexiletine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000768	0.0016	CcSEcCtD
Mexiletine—Vomiting—Bleomycin—lymphatic system cancer	0.000761	0.00159	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—lymphatic system cancer	0.000759	0.00158	CcSEcCtD
Mexiletine—Depression—Methotrexate—lymphatic system cancer	0.000757	0.00158	CcSEcCtD
Mexiletine—Rash—Bleomycin—lymphatic system cancer	0.000755	0.00158	CcSEcCtD
Mexiletine—Dermatitis—Bleomycin—lymphatic system cancer	0.000754	0.00157	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000753	0.00157	CcSEcCtD
Mexiletine—Asthenia—Carmustine—lymphatic system cancer	0.00075	0.00157	CcSEcCtD
Mexiletine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000735	0.00153	CcSEcCtD
Mexiletine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000716	0.00149	CcSEcCtD
Mexiletine—Asthenia—Vincristine—lymphatic system cancer	0.000716	0.00149	CcSEcCtD
Mexiletine—Diarrhoea—Carmustine—lymphatic system cancer	0.000715	0.00149	CcSEcCtD
Mexiletine—Nausea—Bleomycin—lymphatic system cancer	0.000711	0.00148	CcSEcCtD
Mexiletine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000709	0.00148	CcSEcCtD
Mexiletine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000697	0.00146	CcSEcCtD
Mexiletine—Dizziness—Carmustine—lymphatic system cancer	0.000691	0.00144	CcSEcCtD
Mexiletine—Diarrhoea—Vincristine—lymphatic system cancer	0.000683	0.00143	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—lymphatic system cancer	0.000682	0.00142	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000676	0.00141	CcSEcCtD
Mexiletine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000665	0.00139	CcSEcCtD
Mexiletine—Vomiting—Carmustine—lymphatic system cancer	0.000665	0.00139	CcSEcCtD
Mexiletine—Dizziness—Vincristine—lymphatic system cancer	0.00066	0.00138	CcSEcCtD
Mexiletine—Rash—Carmustine—lymphatic system cancer	0.000659	0.00138	CcSEcCtD
Mexiletine—Dermatitis—Carmustine—lymphatic system cancer	0.000659	0.00137	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—lymphatic system cancer	0.000657	0.00137	CcSEcCtD
Mexiletine—Headache—Carmustine—lymphatic system cancer	0.000655	0.00137	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000644	0.00135	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—lymphatic system cancer	0.000635	0.00133	CcSEcCtD
Mexiletine—Vomiting—Vincristine—lymphatic system cancer	0.000635	0.00132	CcSEcCtD
Mexiletine—Rash—Vincristine—lymphatic system cancer	0.000629	0.00131	CcSEcCtD
Mexiletine—Dermatitis—Vincristine—lymphatic system cancer	0.000629	0.00131	CcSEcCtD
Mexiletine—Headache—Vincristine—lymphatic system cancer	0.000625	0.0013	CcSEcCtD
Mexiletine—Nausea—Carmustine—lymphatic system cancer	0.000621	0.0013	CcSEcCtD
Mexiletine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000618	0.00129	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—lymphatic system cancer	0.000613	0.00128	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000612	0.00128	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—lymphatic system cancer	0.000609	0.00127	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—lymphatic system cancer	0.000602	0.00126	CcSEcCtD
Mexiletine—Nausea—Vincristine—lymphatic system cancer	0.000593	0.00124	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000581	0.00121	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—lymphatic system cancer	0.000577	0.0012	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—lymphatic system cancer	0.000559	0.00117	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00055	0.00115	CcSEcCtD
Mexiletine—Malaise—Methotrexate—lymphatic system cancer	0.000535	0.00112	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—lymphatic system cancer	0.000531	0.00111	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—lymphatic system cancer	0.000514	0.00107	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—lymphatic system cancer	0.000505	0.00105	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—lymphatic system cancer	0.000505	0.00105	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—lymphatic system cancer	0.000499	0.00104	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—lymphatic system cancer	0.000488	0.00102	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000474	0.00099	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000468	0.000977	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—lymphatic system cancer	0.000452	0.000944	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000441	0.000921	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000435	0.000908	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000432	0.000901	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—lymphatic system cancer	0.00043	0.000898	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000426	0.00089	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—lymphatic system cancer	0.000417	0.000871	CcSEcCtD
Mexiletine—Pain—Methotrexate—lymphatic system cancer	0.000414	0.000864	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000399	0.000833	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000396	0.000826	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000383	0.000799	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000383	0.000799	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000357	0.000745	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—lymphatic system cancer	0.000347	0.000725	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000331	0.000691	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—lymphatic system cancer	0.00032	0.000668	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—lymphatic system cancer	0.000308	0.000643	CcSEcCtD
Mexiletine—Rash—Methotrexate—lymphatic system cancer	0.000305	0.000637	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—lymphatic system cancer	0.000305	0.000637	CcSEcCtD
Mexiletine—Headache—Methotrexate—lymphatic system cancer	0.000303	0.000633	CcSEcCtD
Mexiletine—Nausea—Methotrexate—lymphatic system cancer	0.000288	0.0006	CcSEcCtD
